A Phase 2 study of ALIMTA in solid tumor patients with stable third-space fluid

Update Il y a 5 ans
Reference: EUCTR2005-005535-10

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective of this Phase 2 study is to evaluate the safety of pemetrexed in patients with third-space fluid (pleural effusions or ascites).


Inclusion criteria

  • either (1) relapsed, advanced (Stage III or IV) NSCLC or (2) malignant pleural or peritoneal mesothelioma